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Abstract 
Intake of whole grains and other food products high in dietary fiber have long been linked to the 
prevention of chronic diseases associated with inflammation. A contribution of the 
gastrointestinal microbiota to these effects has been suggested, but little is known on how whole 
grains interact with gut bacteria. We have recently published the first human trial that made use 
of next-generation sequencing to determine the effect of whole grains (whole grain barley, brown 
rice or a mixture of the two) on fecal microbiota structure and tested for associations between the 
gut microbiota and blood markers of inflammation, glucose and lipid metabolism. Our study 
revealed that whole grains impacted gut microbial ecology by increasing microbial diversity and 
inducing compositional alterations, some of which are considered to have beneficial effects on 
the host. Interestingly, whole grains, and in particular the combination of whole grain barley and 
brown rice, caused a reduction in plasma interleukin-6 (IL-6), which was linked to compositional 
features of the gut microbiota. Therefore, the study provided evidence that a short-term increased 
intake of whole grains led to compositional alterations of the gut microbiota that coincided with 
improvements in systemic inflammation. In this addendum, we summarize the findings of the 
study and provide a perspective on the importance of regarding humans as holobionts when 
considering the health effects of dietary strategies. 
Keywords: inflammation, gut microbiota, metabolic disorders, whole grains 
Introduction 
A substantial body of evidence indicates that the consumption of whole grains reduces the risk 
for several major chronic diseases, such as coronary heart disease (CHD), obesity, type 2 
diabetes and colon cancer.1 The mechanisms by which whole grains exert their benefits are not 
fully understood, but the relevance of inflammation in the development of metabolic diseases2 
and cancer3 has shifted focus to the anti-inflammatory role of whole grains.4 The epidemiological 
evidence for an anti-inflammatory effect of whole grains is consistent, and it concurs with the 
strong epidemiological evidence for a beneficial role in disease prevention.5 However, the 
evidence stemming from interventional studies regarding both the anti-inflammatory role and 
health effects of whole grains is inconclusive.4,5 Several reasons for this discrepancy have been 
debated, but an important confounding factor might be that whole grains differ with respect to 
their composition and health-promoting characteristics. In addition, the microbial populations in 
the gastrointestinal tract (the gut microbiota) have been neglected in nutritional studies on whole 
grains,6 although they are likely to influence the release, fermentation and activation of the 
bioactive compounds present in whole grains.7 The gut microbiota composition is variable in 
humans, and it differs functionally across individuals in its ability to ferment dietary 
carbohydrates,8 constituting a potential confounding factor in studies on the health effects of 
whole grains. 
The gut microbiota has long been hypothesized to play a role in the health effects of whole 
grains.9 Indeed, recent research revealed that virtually all the diseases that show a negative 
correlation with whole grain consumption are also connected to the gut microbiota.10 In animal 
models, the gut microbiota contributes to the development of obesity,11,12 type 2 diabetes,11,12 
CHD,13 and colon cancer,14 likely by exacerbating the different subsets of inflammation that 
contribute to these pathologies.14,15 It is now well established that susceptibility to chronic 
inflammation is affected by both the microbial communities in the gut and the diet, and evidence 
has emerged indicating that diet can both increase and decrease the inflammatory potential of the 
gut microbiota.16-19 A diet high in fat not only causes a microbiota-driven inflammation that 
precedes obesity and insulin resistance in mice,18 but also decreases intestinal epithelial barrier 
function leading to endotoxemia due to increased translocation of bacterial lipopolysaccharide 
(LPS).20 The anti-inflammatory effect of whole grains and their preventive role in diseases 
exacerbated through a microbiota-driven inflammation suggest that some health benefits of 
whole grains are due to their effects on the gut microbiome. Despite this emerging link, very 
little is known about the effect of whole grains on the human gut microbiota and how this effect 
relates to benefits. 
 
A Human Trial to Determine the Effects of Whole Grains on 
Both Human Physiology and the Gut Microbiota 
We have recently completed the first human trial that employed next-generation sequencing to 
determine the effect of whole grains on the composition of the fecal microbiota and tested for 
associations between the bacterial populations and blood markers of inflammation, glucose and 
lipid metabolism.21 The trial was a non-controlled, randomized crossover study with 28 
participants (17 females and 11 males, age 25.9 ± 5.5 y, 13 classified as overweight) with three 
four-week treatments of either whole grain barley (WGB), brown rice (BR) or a mixture of the 
two (WGB+BR) in the form of flakes (60 g daily dose). The first week served as a baseline 
period, and the treatment periods were separated by two-week washout periods (Fig. 1). 
Participants were advised to incorporate the whole grains into their regular diets. Total body 
composition was assessed at baseline, and blood samples were drawn at baseline and at the end 
of each dietary treatment for the determination of fasting glucose and insulin, a lipid profile and 
the inflammatory markers lipopolysaccharide binding protein (LBP), high-sensitivity CRP (hs-
CRP) and IL-6. The glycemic and insulin postprandial response were determined after 
administration of a standard glucose challenge. Fecal samples were collected within 24 h of 
blood collection to facilitate the characterization of fecal microbiota composition (by 454 
amplicon sequencing of the V1-V3 region of the 16S rRNA gene) and short chain fatty acids 




Figure 1. Carbohydrate composition of the whole grains used in the study and trial design. 
Twenty-eight subjects participated in a randomized 17-week crossover study that investigated 
the impact of brown rice (BR), whole-grain barley (WGB) and a combination of the two on gut 
microbiota composition and metabolic and immunological markers. Stool samples and blood 
samples (indicated by red arrows) were collected during the baseline and at the end of each 
treatment period. 
Highly significant positive correlations between body fat and all three inflammatory markers 
were detected in the study population at baseline, substantiating the link between adiposity and a 
low-grade systemic inflammation.2 Interestingly, LBP and hs-CRP were highly correlated (r = 
0.90, p < 0.0001), supporting the relation between bacterial LPS and systemic inflammation and 
the hypothesis of a microbiota-driven endotoxemia.20 Although we did not detect any 
associations between body mass index and the gut microbiota, all three inflammatory markers 
showed negative correlations with the family Ruminococcaceae, and this family was also 
significantly enriched in individuals with low body fat. Within this family, the genera 
Faecalibacterium and Ruminococcus showed negative correlations with hs-CRP. 
Faecalibacterium has been shown to be anti-inflammatory in mouse models of colitis,22 has been 
repeatedly inversely associated with inflammation and has been determined to be less abundant 
in patients who are obese and diabetic,15 but more research is needed to assess the causation of 
these associations in humans. 
 
Whole Grain Intake Reduced Systemic Inflammation and 
Improved Glucose and Lipid Metabolism 
The trial revealed that whole grains led to measurable benefits. A significant decrease in plasma 
IL-6 levels for the WGB+BR treatment vs. baseline values was detected. Quantitatively, this 
reduction was highest in overweight subjects and in females. Despite not achieving statistical 
significance due to high inter-individual variation, hs-CRP plasma levels halved during the 
WGB+BR period when compared with the baseline. Whole grain consumption also improved 
glucose and lipid metabolism. Postprandial peak glucose levels were significantly lowered in 
overweight subjects during the WGB+BR period, fasting glucose levels were significantly 
decreased in women and overweight subjects, and total cholesterol was significantly reduced in 
females. Interestingly, although all treatments led to immunological and metabolic improvements 
(especially in females), it was the combination of whole grains that generated the most 
significant benefits, suggesting a synergistic role between WGB and BR. It is relevant to point 
out that synergistic activities between whole grain varieties provide a potential explanation for 
the discrepancy of the health effects of whole grains obtained in epidemiological and 
interventional studies.4,5,23 Interventional trials might have failed to show benefits because they 
focused on a limited selection of whole grains, while in epidemiological trials, subjects are likely 
to consume a diverse set of whole grains which might have synergistic activities. 
An explanation for the synergism between the whole grains in our study might be interactions of 
their components. The WGB and BR flakes differed markedly in their composition, especially in 
terms of their β-glucan and starch contents (Fig. 1). β-glucan has been shown to modify starch 
digestibility in humans, resulting in reduced postprandial plasma glucose and insulin 
concentrations.24,25 Although the reasons for the observed synergism are unknown, we speculate 
that a possible explanation is that the β-glucan in WGB increased the viscosity of the digesta in 
the small intestine, which in turn reduced starch digestion rate. The notable consequence of 
combined WGB and BR intake, could therefore yield increased starch available in the colon, 
which might have both physiological benefits and an effect on the gut microbiota,26,27 and which 
might increase microbial butyrate production, an anti-inflammatory bacterial metabolite.28 
 
Effects of Dietary Whole Grain Supplementation on Fecal 
Microbial Communities 
The characterization of the fecal microbiota revealed that all three whole grain treatments 
induced detectable compositional alterations. All test meals significantly increased the bacterial 
diversity measured by Shannon’s and Simpson’s indices. Interestingly, intake of prebiotics, 
resistant starches and dietary fibers, do not seem to increase bacterial diversity in the gut.26,29,30 
The compositional complexity of whole grains, which contain a variety of carbohydrates and 
phytochemicals, could potentially support a wider scope of bacterial taxa when compared with 
more homogenous carbohydrates, thereby leading to an increase in diversity. 
Despite substantial inter-individual variation in fecal microbiota composition, whole grain intake 
induced statistically significant changes across the subject population. The proportion of the 
phyla Firmicutes and Bacteroidetes increased and decreased, respectively, with virtually no 
differences between the treatments. While the decrease in phylum Bacteroidetes was to a large 
degree due to a reduction of the genus Bacteroides, the expansion within the Firmicutes was 
more diverse. All whole grain treatments increased the abundance of the genus Blautia and two 
species within this genus, although WGB propitiated a larger increase. Proportions of the genera 
Roseburia, Bifidobacterium and Dialister and the species Eubacterium rectale, Roseburia faecis 
and Roseburia intestinalis increased through WGB intake, and several of these taxa showed a 
gradual increase according to WGB dose. 
Interestingly, the changes in gut microbial ecology induced through whole grains appeared to 
reflect some of the characteristics of the fecal microbiota associated with long-term diets rich in 
plant derived carbohydrates. Individuals from non-westernized societies in Burkina Faso, 
Malawi and the Amazon rain forest of Venezuela, whose regular diet is rich in grains, dietary 
fibers and vegetables, harbor gut bacterial communities that are more diverse and contain lower 
proportions of Bacteroides than individuals from western countries.31,32 In addition, US citizens 
on long-term carbohydrate-rich diets also have decreased levels of Bacteroides when compared 
with individuals with diets high in protein and animal fat.33 However, short-term intake of whole 
grains did not increase the abundance of the genus Prevotella, which is enriched in non-
westernized societies and US individuals on long-term diets rich in polysaccharides.31-33 
Prevotella and Bacteroides appear to exclude each other in the human gut,32 and they are key 
members of recently described distinct clusters within the fecal microbiota referred to as 
enterotypes.34 Enterotypes have been linked to long-term dietary preferences,33 and we therefore 
determined how whole grains influence enterotypes using a clustering analysis. This analysis 
confirmed the presence of three clusters each dominated either by the genera Bacteroides, 
Ruminoccus or Prevotella,34 although the clusters were not discrete, as shown by others,35 and 
instead follow gradients in the abundance of the three defining bacterial species. While whole 
grains reduced the amount of Bacteroides in the study population, they had no effect on 
enterotype membership. However, only the group of subjects that belonged to the “Bacteroides-
enterotype” at baseline showed a significant reduction in Bacteroides (Fig. 2A and B). 
Interestingly, our analysis revealed that enterotype membership within individuals was not 
necessarily stable; some individuals switched enterotypes during the study period due to 
substantial shifts in the genera Bacteroides and Prevotella that seemed unrelated to the dietary 
treatments (Fig. 2C and D). Therefore, our data suggests that enterotypes, if they exist, might not 




Figure 2. Effect of whole grains on the fecal microbiota in relation to bacterial taxa linked to 
enterotypes. Impact of dietary treatments on the abundance of Bacteroides based on whether the 
subject harbored (A) the enterotype dominated by Bacteroides or (B) the other non-Bacteroides 
two enterotypes (Ruminococcus and Prevotella) at baseline. The abundance of the genera 
(C)Bacteroides and (D)Prevotella in fecal samples of all subjects throughout the treatments. 
Dots represent populations within individual fecal samples, color-coded according to enterotypes 
(green = Bacteroides-dominant, red = Ruminococcus-dominant, yellow = Prevotella-dominant). 
Samples of subjects that showed changes in enterotype identity are linked with lines. 
 
Mechanisms by Which Whole Grains Might Influence Gut 
Microbial Ecology 
Whole grains contain an array of non-digestible carbohydrates that reach the colon where they 
can be fermented by bacteria. Dietary carbohydrate intake has been linked to higher levels of 
taxa within the phylum Firmicutes,36 and the increase in this phylum through whole grains is 
likely due to increased availability of carbohydrates in the colon. Although we did not detect an 
increase in fecal SCFA (probably because of their absorption by the host), increased 
carbohydrate fermentation is likely to have resulted in SCFA production, and several of the taxa 
that increased, such as Eubacterium rectale, Roseburia faecis, Roseburia intestinalis and 
bifidobacteria, produce SCFA. Consequently, the luminal pH is likely to have dropped through 
whole grain consumption. This might have caused the decrease in the proportion of Bacteroides, 
which have been shown to be inhibited under acidic conditions (Fig. 3).37 The high content of β-
glucans in WGB probably explains the expansion of bacterial taxa that have the enzymatic 
capability to utilize this substrate, such as Eubacterium rectale and Roseburia intestinalis, which 
showed a dose response with increased consumption of WGB. In contrast to WGB, BR induced 
no significant changes at the species level. This may be explained by the fact that BR does not 
contain a single carbohydrate in high amounts and might be more heterogeneous as a substrate, 
leading to insufficient fractional increases of the individual fibers.38 Accordingly, wheat bran has 
not shown significant changes in the gut microbiota in a previous dietary study.27 The expansion 
of the genus Blautia, which are acetogens that utilize hydrogen, might have been caused by an 





Figure 3. Schematic summary depicting possible mechanisms by which whole grains influence 
the human host and the gut microbiota (see text for details). Red arrows indicate findings 
obtained in the study,21 and black arrows indicate hypothetical changes. 
 
Links Between Whole Grain-Induced Benefits on the Host 
and Fecal Bacterial Communities 
To determine whether effects of whole grains on host phenotypes were associated with the fecal 
microbiota, we first performed a correlation analysis of shifts in bacterial abundance and changes 
in host markers during the WGB+BR period (the treatment that induced the most significant 
improvements). This analysis revealed that increases in the abundance of Eubacterium rectale 
correlated with improvements in postprandial glucose and insulin response. Second, we 
compared the baseline microbiota in subjects that showed different degrees of response to the 
whole grains. This analysis revealed that individuals with the greatest reduction in plasma IL-6 
concentration had significantly higher proportions of Dialister and a lower abundance of the 
Coriobacteriaceae at baseline. 
From the data generated in our study, we can only speculate about the role of the gut microbiota 
in the health benefits of whole grains. Intake of whole grains did not affect the Ruminococcaceae 
or the genus Faecalibacterium, which showed an association with systemic inflammation in the 
baseline population. However, Eubacterium rectale might exert metabolic and immunological 
effects through the production of butyrate.28 Furthermore, the whole grain-induced increases of 
bifidobacteria and Roseburia species, which have been suggested to affect immune/inflammatory 
and metabolic functions in animal models,12,40 might benefit the host. The associations of 
baseline populations of Dialister and Coriobacteriaceae with IL-6 response suggest that these 
taxa may condition the capability of an individual to be immunologically responsive to whole 
grains. It has been suggested that most of the phytochemicals present in whole grains are bound 
to carbohydrates and are not absorbed unless released through bacterial action in the colon,23 and 
Dialister might possess such activities. Coriobacteriaceae have been shown to be increased in 
patients with Crohn disease and colitic mice and might be pro-inflammatory.41 
 
Conclusion and Perspective 
Our study21 has provided the first look into the relationship between whole grains, the gut 
microbiota and host metabolism and showed that whole grain-induced alterations in the 
characteristics and composition of the fecal microbiota coincided with immunological and 
metabolic benefits. The associations between the reduction of IL-6 and the presence of certain 
bacterial taxa (Dialister, Coriobacteriaceae) indicate a functional role of gut bacteria in the 
physiological effects of whole grains, which has long been hypothesized.9,23 
However, this study had limitations in the elucidation of mechanistic interactions and causation 
in the detected associations among diet, the gut microbiome and host metabolism. By relying 
solely on 16S rRNA tag sequencing, our study could not provide insight into the impact of whole 
grains on the metabolism of the gut microbiota and the microbial transformation of the bioactive 
phytochemicals. Future research should therefore combine metagenomic and metabolomic 
approaches with physiological studies of cultural isolates to characterize how bioactive 
compounds in whole grains become metabolized, released and modified by bacteria in the colon 
and how this correlates with effects on the host. Moreover, several of the beneficial effects of 
whole grains might be mediated without microbial contributions and correlations could result 
from the host and the microbiome responding independently to the diet. Therefore, the impact of 
whole grain diets (and other nutritional strategies) on host health should be compared in 
conventional and germ-free animals to separate direct vs. microbiota-mediated effects. Such a 
tractable model would then allow addition of cultured strains with specific characteristics to 
identify bacterial contributors and the underlying mechanisms. 
The findings obtained in this study suggest that the gut microbiota might condition the health 
effects of whole grains. As the human gut microbiota is individualized, variations in the 
microbial communities could have functional consequences in terms of the host’s ability to 
process and release the bioactive compounds, phytochemicals and antioxidants present in whole 
grains. This would lead to higher levels of variation in intervention trials, and it clearly poses 
hurdles to developing universal dietary recommendations. Future studies should be aimed to 
determine bacterial groups that are linked to the health benefits of specific whole grains and to 
elucidate the underlying mechanisms. Such knowledge will ultimately allow us to develop more 
personalized nutritional strategies that consider the individual’s microbiota. 
It is now becoming apparent that humans can be seen as holobionts that function and evolve not 
as single organisms but as an amalgam of host and symbiotic microbial communities, with their 
interactions influencing all aspects of human biology and health.42 Diet is a key factor that 
shapes the gut microbiota, which is the densest and probably the most important of the host-
associated microbial communities. It is striking that whole-grains and resistant starches, both 
which provide substrates for the bacteria in the colon, show metabolic and immunological 
benefits related to the chronic diseases linked to the microbiome. The field of Nutrigenomics, 
which aims to use an individual’s genetic makeup to optimize nutrition, should therefore be 
extended to include the metagenome as well. This would ultimately result in something we might 
want to call “Holobiont Nutrition”, a holistic approach that considers not only our own 
nutritional requirements but also that of our symbiotic microbial communities and the 
interactions between the two entities. Given the importance of the microbiome for health, this 
approach has the potential to improve human nutrition substantially. 
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